These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 32171530

  • 1. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
    Han X, Ding C, Zhang G, Pan R, Liu Y, Huang N, Hou N, Han F, Xu W, Sun X.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):895-901. PubMed ID: 32171530
    [Abstract] [Full Text] [Related]

  • 2. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFκB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice.
    Ding X, Jian T, Li J, Lv H, Tong B, Li J, Meng X, Ren B, Chen J.
    Oxid Med Cell Longev; 2020 May 14; 2020():9734560. PubMed ID: 33204402
    [Abstract] [Full Text] [Related]

  • 3. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q, Sha S, Sun L, Zhang J, Dong M.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):196-203. PubMed ID: 27208776
    [Abstract] [Full Text] [Related]

  • 4. Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice.
    Sun X, Han F, Lu Q, Li X, Ren D, Zhang J, Han Y, Xiang YK, Li J.
    Diabetes; 2020 Jun 05; 69(6):1292-1305. PubMed ID: 32234722
    [Abstract] [Full Text] [Related]

  • 5. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
    Qu LL, Yu B, Li Z, Jiang WX, Jiang JD, Kong WJ.
    Phytother Res; 2016 Mar 05; 30(3):402-11. PubMed ID: 26634892
    [Abstract] [Full Text] [Related]

  • 6. Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice.
    Ye J, Tian X, Wang Q, Zheng J, Yang Y, Xu B, Zhang S, Yuan F, Yang Z.
    Mar Drugs; 2022 May 05; 20(5):. PubMed ID: 35621963
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY, Zhang LL, Suolang QZ, Yang GY, Li L, Li SB, Chen WW.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov 05; 22(11):849-53. PubMed ID: 25531383
    [Abstract] [Full Text] [Related]

  • 9. Baicalin ameliorates high fat diet-induced nonalcoholic fatty liver disease in mice via adenosine monophosphate-activated protein kinase-mediated regulation of SREBP1/Nrf2/NF-κB signaling pathways.
    Gao Y, Liu J, Hao Z, Sun N, Guo J, Zheng X, Sun P, Yin W, Fan K, Li H.
    Phytother Res; 2023 Jun 05; 37(6):2405-2418. PubMed ID: 36752274
    [Abstract] [Full Text] [Related]

  • 10. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD.
    Li J, Wang T, Liu P, Yang F, Wang X, Zheng W, Sun W.
    Food Funct; 2021 May 11; 12(9):3898-3918. PubMed ID: 33977953
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y, Chen J, Gao Q, Shan X, Wang J, Lv Z.
    Toxicology; 2020 Dec 01; 445():152599. PubMed ID: 32976958
    [Abstract] [Full Text] [Related]

  • 16. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L, Wang T, Li W, Zhang J, Zheng C, Zheng Y, Li S, Shang Z, Lin J, Wang F, Qian Y, Zhou Z, Kong X, Gao Y, Sun X.
    J Ethnopharmacol; 2024 Jul 15; 329():118165. PubMed ID: 38588984
    [Abstract] [Full Text] [Related]

  • 17. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.
    Tao W, Sun W, Liu L, Wang G, Xiao Z, Pei X, Wang M.
    Mar Drugs; 2019 Nov 16; 17(11):. PubMed ID: 31744059
    [Abstract] [Full Text] [Related]

  • 18. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis.
    Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, Fan K, Liu J, Zhu Y, Wang Z, Zhang Y, Chen L.
    Mol Med; 2023 Sep 28; 29(1):132. PubMed ID: 37770820
    [Abstract] [Full Text] [Related]

  • 19. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of the glucagon-like peptide-1 analogue liraglutide on carbon tetrachloride-induced acute liver injury in mice.
    Zhang WY, Hu XF, Wan N, Zhang JF, Yang P, Wen Q, Chen WJ, Zhu F, Liang ML, Cheng LX, Shu YW.
    Biochem Biophys Res Commun; 2019 Jun 25; 514(2):386-392. PubMed ID: 31047638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.